From: The clinical and radiological effectiveness of autologous bone marrow derived osteoblasts (ABMDO) in the management of avascular necrosis of femoral head (ANFH) in sickle cell disease (SCD)
Age (Years)
25.93 ± 5.48
Females
41
Males
22
Ficat I
5
Ficat II
47
Ficat III
11
Follow Up (Months)
40.05 ± 8.9 (range 24–48)